August 03, 2015 Dr. Anthony Nichols has received $515,090 for his research on head and neck cancer. The disease and its treatment can have a profound negative impact on patient quality of life in terms of speech, the ability to eat, facial disfigurement and pain. Only one half of patients with advanced disease survive making the need to develop more effective and less toxic therapies important. PI3K inhibitors are a class of drug that have shown promise in treating a variety of cancers. Dr. Nichols research will focus on identifying the genetic changes involved in cancer cells to determine which tumours are susceptible to these drugs and how drug resistance can be prevented.
January 09, 2015 It isn't commonly known, but head and neck cancers have quietly become the second fastest growing form of the disease in North America.
In an effort to combat this problem, the men and women behind the Manuary Campaign are preparing for the 5th annual London event, in which the Head and Neck Surgery Department at London Health Sciences Centre (LHSC) aims to raise $25,000 to support ongoing research.